SCHEMBL23382533

SCHEMBL23382533

CCC1(Oc2ccc(C(=O)OC(c3ccccc3)C(F)(F)C(=O)O)cc2)CCCC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FFAR1 O14842 1/20 0.39
▸ KMT2A Q03164 6/20 0.37
▸ MEN1 O00255 5/20 0.37
▸ MAPT P10636 4/20 0.37
▸ RAB9A P51151 3/20 0.37
▸ POLB P06746 1/20 0.37
▸ NPC1 O15118 1/20 0.37
▸ SMN1; SMN2 Q16637 5/20 0.35
▸ LMNA P02545 3/20 0.35
▸ MITF O75030 2/20 0.35
▸ SLC6A4 P31645 2/20 0.35
▸ SLC6A3 Q01959 2/20 0.35
▸ NLRP1 Q9C000 1/20 0.35
▸ SLC6A2 P23975 1/20 0.35
▸ NPSR1 Q6W5P4 2/20 0.35
▸ CYP1A2 P05177 1/20 0.35
▸ CYP3A4 P08684 1/20 0.35
▸ CYP2D6 P10635 1/20 0.35
▸ CYP2C9 P11712 1/20 0.35
▸ CYP2C19 P33261 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23382527 0.99 FFAR1 (0.39) FFAR1KMT2AMEN1MAPTRAB9A
SCHEMBL23382829 0.89 FFAR1 (0.36) FFAR1KMT2AMEN1MAPTRAB9A
SCHEMBL23382830 0.88 FFAR1 (0.36) FFAR1KMT2AMEN1MAPTRAB9A
SCHEMBL23382722 0.88 SLC6A2 (0.37) FFAR1KMT2AMEN1MAPTRAB9A
SCHEMBL23382723 0.87 SLC6A2 (0.39) FFAR1KMT2AMEN1MAPTRAB9A
SCHEMBL23382530 0.86 KMT2A (0.39) FFAR1KMT2AMEN1MAPTRAB9A
SCHEMBL23382532 0.85 KMT2A (0.38) FFAR1KMT2AMEN1MAPTRAB9A
SCHEMBL23382526 0.84 RAB9A (0.37) FFAR1KMT2AMEN1MAPTRAB9A
SCHEMBL23382531 0.83 KMT2A (0.37) FFAR1KMT2AMEN1MAPTRAB9A
SCHEMBL23382456 0.83 L3MBTL1 (0.35) KMT2AMEN1SMN1; SMN2LMNASLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11762287-B2 Onium salt compound, chemically amplified resist composition and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-09-19 — — US disclosed
US-11762287-B2 Onium salt compound, chemically amplified resist composition and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-09-19 — — US disclosed
US-20210149301-A1 ONIUM SALT COMPOUND, CHEMICALLY AMPLIFIED RESIST COMPOSITION AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2021-05-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11762287-B2 Onium salt compound, chemically amplified resist composition and patterning process IDUA, SLC6A5, SLC6A9 FFAR1 1497/4885KMT2A 2745/4885MEN1 3334/4885
US-20210149301-A1 ONIUM SALT COMPOUND, CHEMICALLY AMPLIFIED RESIST COMPOSITION AND PATTERNING PROCESS IDUA, SLC6A5, SLC6A9 FFAR1 1497/4885KMT2A 2745/4885MEN1 3334/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback